TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients

TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients

Publication: Clin Cancer Res

Purpose: Recent advances in immunotherapy of advanced human cancers underscored the need to address and eliminate tumor immune evasion. The myeloid-derived...

5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII

5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII

Publication: Bioorg Med Chem
Software: ADMET Predictor®

Inhibitory activity of a congeneric set of 23 phenyl-substituted 5-phenyl-pyrazole-3-carboxylic acids toward human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms I, II, IX and XII was evaluated by a stopped-flow CO2 hydrase assay.

Ranking the binding energies of p53 mutant activators and their ADMET properties

Ranking the binding energies of p53 mutant activators and their ADMET properties

Authors: Omar SI, Tuszynski JA
Publication: Chem Biol Drug Des
Software: ADMET Predictor®

The guardian of the genome, p53, is the most mutated protein found in all cancer cells. Restoration of wild-type activity to mutant p53 offers promise to eradicate cancer cells using novel pharmacological agents.

Warfarin-dependent gamma-carboxylation regulates androgen receptor activity

Warfarin-dependent gamma-carboxylation regulates androgen receptor activity

Publication: Endocrinology
Division: Simulations Plus

The anti-coagulant warfarin prevents the gamma-carboxylation (gla) of target proteins by interfering with the vitamin K cycle through its inhibition of the vitamin K epoxide...

Role of computer-aided drug design in modern drug discovery

Role of computer-aided drug design in modern drug discovery

Publication: Arch Pharm Res
Software: ADMET Predictor®

Drug discovery utilizes chemical biology and computational drug design approaches for the efficient identification and optimization of lead compounds.

TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells

TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells

Publication: Oncotarget

Prostate cancer progression was associated with tumorigenic signaling activated by proinflammatory mediators. However, the etiology of these events remains elusive.

Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs

Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs

Publication: AAPS J
Software: GastroPlus®

During the last decades, the importance of modeling and simulation in clinical drug development, with the goal to qualitatively and quantitatively assess and understand mechanisms of pharmacokinetic processes...

Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models

Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models

Publication: AAPS J
Software: GastroPlus®

In vitro and in vivo experimental models are frequently used to assess a new chemical entity's (NCE) biopharmaceutical performance risk for food effect (FE) in humans.

Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems

Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems

Publication: J Control Release
Software: GastroPlus®

The objective of this study was to develop a level A in vitro-in vivo correlation (IVIVC) for drug-in-adhesive (DIA) type estradiol transdermaldrug delivery systems (TDDS).

Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment

Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment

Publication: Toxicology
Software: GastroPlus®

Risk assessment methodologies in toxicology have remained largely unchanged for decades. The default approach uses high dose animal studies, together with human exposure estimates...

Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions

Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions

Authors: Hosey CM, Benet LZ
Publication: Mol Pharm
Software: ADMET Predictor®

The Biopharmaceutics Drug Disposition Classification System (BDDCS) can be utilized to predict drug disposition, including interactions with other drugs and transporter or metabolizing enzyme effects based...

An in silico expert system for the identification of eye irritants

An in silico expert system for the identification of eye irritants

Authors: Verma RP, Matthews EJ
Publication: SAR QSAR Environ Res
Software: ADMET Predictor®

This report describes development of an in silico, expert rule-based method for the classification of chemicals into irritants or non-irritants to eye, as defined by the Draize test.

Discovery of a Potent, Orally Available Dual CysLT1 and CysLT2 Antagonist with Dicarboxylic Acid

Discovery of a Potent, Orally Available Dual CysLT1 and CysLT2 Antagonist with Dicarboxylic Acid

Publication: Bioorg Med Chem
Software: ADMET Predictor®

A potent, orally available dual CysLT1 and CysLT2 receptor antagonist with a dicarboxylic acid is described. 4-(3-(Carboxymethyl)-4-{(E)-2-[4-(4-phenoxybutoxy)phenyl]vinyl}-1H-indol-1-yl)butanoic acid...

Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem

Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem

Publication: AAPS J
Software: GastroPlus®
Division: Simulations Plus

Intraoral (IO) delivery is an alternative administration route to deliver a drug substance via the mouth that provides several advantages over conventional oral dosage forms.